Will Mexico's COFEPRIS Dissolve Under New Presidency?
Executive Summary
Newly inaugurated Mexican President Andrés Manuel López Obrador may restructure drug regulator in quest to centralize government's public health services.
You may also be interested in...
Could New Governments In Brazil, Mexico Derail International Regulatory Convergence?
Bayer's Patrick Brady says nationalist sentiments raise concerns, but he remains hopeful that technology and progress will continue to drive globalization.
Mexico and Argentina To Cut Burden for Pharma By Swapping GMP Reports
Medicines regulators in Mexico and Argentina have agreed to exchange good manufacturing practices inspection certificates.
US-Mexico-Canada Trade Agreement Sets 10-Year Floor For Biologics Market Exclusivity
USA's 12-year-plus scheme won't change, but Canada and Mexico must offer sponsors more than previously; biosimilar industry bemoans lack of incentives for competition. Trade pact also specifies damages award options and links regulatory review to patent disputes.